Jubilant Ingrevia Limited has announced key dates for its Q3FY26 financial results disclosure, scheduling a board meeting on February 4, 2026, followed by an investor conference call on February 5, 2026. The company will review its unaudited financial performance for the quarter ended December 31, 2025.

Board Meeting and Conference Call Schedule

The company has formally notified stock exchanges about the upcoming board meeting and subsequent investor engagement activities. The board will deliberate on comprehensive financial data before presenting results to stakeholders.

Conference Call Details

The management team will host a conference call for analysts and investors on February 5, 2026, at 5:00 PM IST. The session will commence with a brief management discussion on financial performance, followed by an interactive Question & Answer session.

Regulatory Compliance and Market Communication

Jubilant Ingrevia has fulfilled its obligations under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notifications were sent to BSE Limited (scrip code 543271) and National Stock Exchange of India Limited (trading symbol JUBLINGREA).

The company has committed to making financial results simultaneously available on its corporate website at www.jubilantingrevia.com once the board meeting concludes. This ensures immediate access for all stakeholders including investors, analysts, and market participants.

Pre-registration and Access

To enable seamless participation, the company offers pre-registration for the conference call through Diamond Pass Log-In. Participants can register in advance to receive dial-in numbers, passcode, and PIN via email. The audio link will also be accessible through the company's investor relations section at https://jubilantingrevia.com/investors/financials/quarterly-results .

Company Secretary Deeptanjali Gulati signed the notifications on January 19, 2026, demonstrating adherence to proper corporate governance procedures and timely market communication practices.

Jubilant Ingrevia Limited has received a GST demand order from tax authorities for financial year 2017-18, with the company disclosing the development under regulatory compliance requirements on December 26, 2025.

GST Demand Details

The Joint Commissioner (Appeals), State Tax, Pune has confirmed a GST demand against the company's Nira plant through an appeal order. The total financial impact of the confirmed demand amounts to ₹2.18 crores across multiple components.

Nature of Violation

The GST authorities have alleged wrong availment and utilization of Input Tax Credit in violation of Section 16 of the GST Act, 2017. The order was passed under reference number JC/APP-02/GST-18/23-24/27AABCV0200H1ZW/Jubilant Pharmova Limited/ORDER/25-26/136, dated December 11, 2025, and was received by the company on December 26, 2025, at 13:06 pm.

Company's Response Strategy

Jubilant Ingrevia has indicated its intention to challenge the demand order through the appropriate legal channels. The company is in the process of taking necessary action to file an appeal before the GST Appellate Tribunal (GSTAT) against the impugned demand order raised by the GST authorities.

Financial Impact Assessment

The company has assessed that it has a strong case to defend on merits and expects no material financial or operational impact from this development. This assessment suggests the company's confidence in successfully challenging the demand through the appellate process.

Regulatory Compliance

The disclosure was made pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, in compliance with the SEBI Master Circular dated November 11, 2024. The company has simultaneously posted the relevant documentation on its official website at www.jubilantingrevia.com .